Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9429191 | Neuroscience Letters | 2005 | 5 Pages |
Abstract
In the present study, we evaluated the potential neuroprotective effect of granulocyte colony-stimulating factor (G-CSF), a hematopoietic growth factor in two different culture models in which dopaminergic (DA) neurons die selectively: first, in a culture model in which death of DA neurons occurs spontaneously and second, in a toxin-based paradigm, the in vitro 1-methyl-4-phenylpyridinium model of PD. In neither of the two models, a treatment with G-CSF, could prevent or halt the progressive neurodegeneration. However, we cannot rule out that G-CSF might exert neuroprotective or even deleterious effects in in vivo models of PD, based on the significant increase in the number of microglial cells observed after G-CSF treatment.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Carmen Henze, Thomas Lescot, Sabine Traver, Bénédicte Salthun-Lassalle, Etienne C. Hirsch, Patrick P. Michel, Andreas Hartmann,